Is angiogenesis essential for the progression of hematological malignancies or is it an epiphenomenon?

Leukemia

Volumn 23, Issue 3, 2009, Pages 433-434

  Ribatti, D ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BASIC FIBROBLAST GROWTH FACTOR; CYTOKINE; CYTOTOXIC AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ANGIOGENESIS; B CELL LYMPHOMA; CANCER CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CELL PROLIFERATION; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; DISEASE COURSE; DRUG EFFICACY; EDITORIAL; HEMATOLOGIC MALIGNANCY; HUMAN; LEUKEMIA; MALIGNANT TRANSFORMATION; METASTASIS; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; PLASMA CELL; PRIORITY JOURNAL;

EID: 62549147784     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2008.381     Document Type: Editorial

References (12)

1. Ribatti D, Vacca A, Dammacco F. The role of the vascular phase in solid tumor growth: A historical review. Neoplasia 1999; 1: 293-302.
2. Folkman J. Regulation of angiogenesis. Presented at the 35th Annual Meeting of the American Society of Hematology, St Louis, MO, 3-7 December 1993.
3. Nguyen M, Watanabe H, Budson AE, Richie JP, Hayes DF, Folkman J. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst 1994; 86: 356-361.
4. Brunner G, Nguyen H, Gabrilove J, Rifkin DB, Wilson EL. Basic fibroblast growth factor expression in human bone marrow and peripheral blood cells. Blood 1993; 81: 631-638.
5. Vacca A, Ribatti D, Roncali L, Ranieri G, Serio G, Silvestris F et al Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol 1994; 87: 503-508.
6. Ribatti D, Vacca A, Nico B, Fanelli M, Roncali L, Dammacco F. Angiogenesis spectrum in the stroma of B-cell non-Hodgkin's lymphomas. An immunohistochemical and ultrastructural study. Eur J Haematol 1996; 56: 45-53.
7. Molica S, Vacca A, Ribatti D, Cuneo F, Cavazzini D, Levato G et al Prognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphocytic leukemia. Blood 2002; 100: 3344-3351.
8. Perez-Atayde AR, Sallan SE, Tedrow U, Connors S, Allred E, Folkman J. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol 1997; 150: 815-821.
9. Hussong JW, Rodgers GM, Shami PJ. Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood 2000; 95: 309-313.
10. Lundberg LG, Lerner R, Sundelin P, Rogers R, Folkman J, Palmblad J. Bone marrow in polycythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascularity. Am J Pathol 2000; 157: 15-19.
11. Pruneri G, Bertolini F, Soligo D, Carboni N, Cotrelezzi A, Ferrucci PF et al. Angiogenesis in myelodysplastic syndromes. Br J Cancer 1999; 81: 1398-1401.
12. Mesa RA, Hanson Ca, Rajkumar SV, Schroeder G, Tefferi A. Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myleoid metaplasia. Blood 2000; 96: 3374-3380.